ROCEPHIN FOR INJECTION 500 mg/vial (INTRAVENOUS)

Country: Singapor

Lingwa: Ingliż

Sors: HSA (Health Sciences Authority)

Ixtrih issa

Ingredjent attiv:

CEFTRIAXONE DISODIUM EQV CEFTRIAXONE

Disponibbli minn:

ROCHE SINGAPORE PTE. LTD.

Kodiċi ATC:

J01DD04

Dożaġġ:

500 mg/vial

Għamla farmaċewtika:

INJECTION, POWDER, FOR SOLUTION

Rotta amministrattiva:

INTRAVENOUS

Tip ta 'preskrizzjoni:

Prescription Only

Manifatturat minn:

F HOFFMANN-LA ROCHE LTD

Data ta 'l-awtorizzazzjoni:

1988-04-29

Fuljett ta 'informazzjoni

                                ROCEPHIN®
 
Ceftriaxone 
 
BROAD-SPECTRUM CEPHALOSPORIN ANTIBIOTIC  
1. DESCRIPTION 
1.1 
THERAPEUTIC / PHARMACOLOGIC CLASS OF DRUG 
Rocephin is a long acting, broad spectrum cephalosporin antibiotic
for parenteral use. 
1.2 
TYPE OF DOSAGE FORM 
Powder for solution for injection  
Powder for solution for infusion  
1.3 ROUTE 
OF 
ADMINISTRATION 
•  intramuscular injection 
•  intravenous injection 
•  intravenous infusion 
1.4 
STERILE / RADIOACTIVE STATEMENT 
Not applicable 
1.5 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
_Active ingredient:_ ceftriaxone in the form of the
disodium salt. 
Vials containing dry substance equivalent to 0.25 g, 0.5 g, 1 g or 2
g ceftriaxone. 
_Solvent for parenteral use:_ The solvent ampoule for i.v. injection
contains sterile water for 
injections and for i.m. injection contains 1% lidocaine
hydrochloride solution. 1 ml solvent for 
i.m. injection contains 10.66 mg lidocaine hydrochloride monohydrate
equivalent to 10 mg 
anhydrous lidocaine hydrochloride. 
Rocephin contains approximately 83 mg (3.6 mEq) of sodium per
gram of ceftriaxone. 
2. CLINICAL
 
PARTICULARS 
2.1 THERAPEUTIC 
INDICATION(S) 
Infections caused by pathogens sensitive to Rocephin, e.g.: 
− sepsis; 
− meningitis; 
− disseminated Lyme borreliosis (early and late stages of the
disease); 
− abdominal infections (peritonitis, infections of the biliary and
gastrointestinal tracts); 
 
1
− infections of the bones, joints, soft tissue, skin and of
wounds; 
− infections in patients with impaired defense mechanisms; 
− renal and urinary tract infections; 
− respiratory tract infections, particularly pneumonia, and
ear, nose and throat infections; 
− genital infections, including gonorrhea. 
 And perioperative prophylaxis of infections. 
2.2 
DOSAGE AND ADMINISTRATION 
_STANDARD DOSAGE _
Adults and children over 12 years 
The usual dosage is 1-2 g of Rocephin once daily (every 24 hours). In
severe cases or in 
i
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott